Chemoinformaics analysis of (3Z)-HEXA-1,3-DIENE
| Molecular Weight | 82.146 | nRot | 2 |
| Heavy Atom Molecular Weight | 72.066 | nRig | 1 |
| Exact Molecular Weight | 82.0782 | nRing | 0 |
| Solubility: LogS | -6.941 | nHRing | 0 |
| Solubility: LogP | 7.874 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 16.6879 |
| nHD | 0 | BPOL | 10.0321 |
| QED | 0.271 |
| Synth | 1.977 |
| Natural Product Likeliness | 1.11 |
| NR-PPAR-gamma | 0.133 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.006 |
| HIA | 0.002 |
| CACO-2 | -4.596 |
| MDCK | 0.00000901 |
| BBB | 0.17 |
| PPB | 0.981539 |
| VDSS | 4.18 |
| FU | 0.0186548 |
| CYP1A2-inh | 0.646 |
| CYP1A2-sub | 0.194 |
| CYP2c19-inh | 0.481 |
| CYP2c19-sub | 0.073 |
| CYP2c9-inh | 0.218 |
| CYP2c9-sub | 0.952 |
| CYP2d6-inh | 0.198 |
| CYP2d6-sub | 0.122 |
| CYP3a4-inh | 0.294 |
| CYP3a4-sub | 0.054 |
| CL | 5.09 |
| T12 | 0.093 |
| hERG | 0.132 |
| Ames | 0.006 |
| ROA | 0.026 |
| SkinSen | 0.956 |
| Carcinogencity | 0.053 |
| EI | 0.955 |
| Respiratory | 0.097 |
| NR-Aromatase | 0.052 |
| Antiviral | No |
| Prediction | 0.948376 |